常染色体隐性遗传性感音神经性听力损失产前扩展性遗传病携带者筛查结果的管理
回顾性分析15例产前扩展性携带者筛查(ECS)提示常染色体隐性遗传性感音神经性听力损失(SNHL)基因阳性的母婴对,其中14例为GJB2致病变异、1例为USH2A。6例婴儿遗传双等位基因GJB2突变,4例在5周龄前经ABR诊断为SNHL并接受随访管理。作者认为携带者筛查及产前或新生儿确诊性基因检测可为早期听力学检测和助听器验配等干预提供充足提前量。
要点
- 产前ECS可早期识别SNHL风险,为预后判断和早期教育干预提供窗口。
- 15例阳性孕妇中14例为GJB2致病变异、1例为USH2A。
- 6例婴儿遗传双等位基因GJB2突变,4例在5周龄前ABR诊断SNHL并随访。
核心结论
- 携带者筛查及产前或新生儿确诊性基因检测为早期听力学检测和包括助听器验配在内的适当干预服务提供了充足的提前量。
研究设计与样本
- 回顾性病历审查,纳入学术三级医院母胎医学中心与耳鼻咽喉科的母婴对,其ECS结果提示常染色体隐性遗传SNHL基因变异阳性。
主要发现
- 15例孕妇ECS结果提示SNHL阳性并转诊至小儿耳鼻咽喉科医生和遗传咨询师处咨询,这些夫妇通常受教育程度高且保险充足。
- 14例携带GJB2致病变异、1例携带USH2A致病变异。
- 4对夫妇经羊膜腔穿刺进行产前遗传学诊断,11对夫妇将基因检测推迟至出生后或等待初次听力评估。
- 6例婴儿遗传双等位基因GJB2突变;4例在5周龄前经ABR发现SNHL并接受随访管理,1例虽基因阳性但听力评估正常,1例在听力评估前失访。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Expanded carrier screening (ECS) identified couples at-risk to have a baby with an autosomal recessive genetic condition. Several genes implicated in sensorineural hearing loss (SNHL) are included in prenatal or preconception genetics ECS testing. Early identification of SNHL risk may enable prognostication of hearing loss, early educational intervention, and minimization of unnecessary diagnostic testing. We sought to describe cases where ECS enabled early SNHL-risk identification. STUDY DESIGN: Retrospective chart review. SETTING: Maternal-Fetal Care Center and Otolaryngology department at an academic tertiary hospital. METHODS: Medical records of parent-infant dyads with positive ECS results for variants in autosomal recessive SNHL genes were reviewed. Data regarding genetic diagnostic testing, newborn hearing screening, time to HL diagnosis, audiological evaluation, and clinical consultations were compiled. RESULTS: Fifteen pregnant with positive ECS results for SNHL were referred for consultation with a pediatric otolaryngologist and genetic counselor. Generally, these couples were highly educated and adequately insured. 14 had pathogenic variants for GJB2 and 1 for USH2A. Four couples pursued prenatal genetic diagnosis via amniocentesis; 11 couples deferred genetic testing to the postnatal period or waited for initial hearing evaluation. Six babies inherited biallelic GJB2 mutations. Four were found to have SNHL on ABR by age 5 weeks and received follow-up management, 1 had a normal hearing evaluation despite being gene-positive, and 1 was lost to follow-up before hearing evaluation. CONCLUSIONS: Carrier screening and confirmatory prenatal or neonatal genetic testing provided considerable lead time for early audiometric testing and appropriate intervention services including hearing aid fitting.
引用
- Srinivasan T, Redfield S, Poorvu T, et al. Management of Prenatal Expanded Genetic Carrier Screening Results for Autosomal Recessive Sensorineural Hearing Loss. Otolaryngol Head Neck Surg. 2024. PMID: 39523564. doi:10.1002/ohn.1028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。